Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders
Targeted Drug Delivery The therapeutic efficacy of small molecules, proteins, and oligonucleotides for treating neurological disorders remains a challenge due to the presence of the blood-brain barrier (BBB). Multifunctional nanomaterials have emerged as promising vehicles for targeted drug delivery to the brain, due to their ability to transport therapeutics across the BBB selectively. More in article number 2400232, Ki-Bum Lee and co-workers.
Authors
- Sarah Nevins
- Mehrdad Khakbiz (ORCID: https://orcid.org/0000-0002-4930-7930)
- Joshua B. Stein (ORCID: https://orcid.org/0000-0002-6833-693X)
- Callan D. McLoughlin (ORCID: https://orcid.org/0000-0002-9555-3534)
- Ki‐Bum Lee (ORCID: https://orcid.org/0000-0002-8164-0047)
Institutions
- Rutgers, The State University of New Jersey (US)
- Kyung Hee University (KR)
Publication Details
- Journal
- Small Science
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/smsc.202470050
- Citations
- 3
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.52